Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis

MLA

Kalincik, T., et al. Effectiveness of Autologous Haematopoietic Stem Cell Transplantation versus Natalizumab in Progressive Multiple Sclerosis. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1456028121&authtype=sso&custid=ns315887.

APA

Kalincik, T., Sharmin, S., Massey, J., Sutton, I., Withers, B., Freedman, M., Atkins, H., Krasulova, E., Havrdova, E., Trneny, M., Kozak, T., Burman, J., MacDonell, R., Torkildsen, Ø., Bø, L., Lehmann, A., Sharrack, B., & Snowden, J. (2024). Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis.

Chicago

Kalincik, T, S Sharmin, J Massey, I Sutton, B Withers, Ms Freedman, H Atkins, et al. 2024. “Effectiveness of Autologous Haematopoietic Stem Cell Transplantation versus Natalizumab in Progressive Multiple Sclerosis.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1456028121&authtype=sso&custid=ns315887.